KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-Current Deferred Tax Liability (2016 - 2026)

Emergent BioSolutions has reported Non-Current Deferred Tax Liability over the past 11 years, most recently at $33.3 million for Q1 2026.

  • For Q1 2026, Non-Current Deferred Tax Liability fell 44.87% year-over-year to $33.3 million; the TTM value through Mar 2026 reached $33.3 million, down 44.87%, while the annual FY2025 figure was $37.8 million, 22.7% down from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 was $33.3 million at Emergent BioSolutions, down from $37.8 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $125.4 million in Q4 2022 and troughed at $33.3 million in Q1 2026.
  • A 5-year average of $60.7 million and a median of $52.4 million in 2023 define the central range for Non-Current Deferred Tax Liability.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 114.91% in 2022 and later tumbled 53.99% in 2023.
  • Year by year, Non-Current Deferred Tax Liability stood at $125.4 million in 2022, then crashed by 53.03% to $58.9 million in 2023, then decreased by 16.98% to $48.9 million in 2024, then dropped by 22.7% to $37.8 million in 2025, then fell by 11.9% to $33.3 million in 2026.
  • Business Quant data shows Non-Current Deferred Tax Liability for EBS at $33.3 million in Q1 2026, $37.8 million in Q4 2025, and $36.3 million in Q3 2025.